Supplier News

Oct 19, 2018
By BioPharm International Editors
The companies will work together to advance a number of Morphic's oral integrin therapeutics for fibrosis-related indications in a deal with $100 million.
Oct 18, 2018
By BioPharm International Editors
The contract development and manufacturing organization released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.
Oct 15, 2018
By BioPharm International Editors
The company was awarded for excellence in innovation for Parteck MXP Excipient and modified amino acids.
Oct 15, 2018
By BioPharm International Editors
The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.
Oct 12, 2018
By BioPharm International Editors
The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.
Oct 11, 2018
By BioPharm International Editors
The new facility will include comprehensive mammalian process development and manufacturing capabilities.
Oct 09, 2018
By BioPharm International Editors
The UCL-Pall Biotech Centre of Excellence will address industry challenges and provide workforce training.
Oct 03, 2018
By BioPharm International Editors
The companies will work together to discover, develop, and commercialize immunotherapies for patients with solid-tumor cancers in a collaboration worth $695 million per program.
Oct 01, 2018
By BioPharm International Editors
Kangstem Biotech has selected Orgenesis subsidiary, MaSTherCell, as its contract manufacturing partner for the European clinical trial of Furestem-AD.
Oct 01, 2018
By BioPharm International Editors
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
native1_300x100
lorem ipsum